Meet Our Team
Dr. Josephin Holstein
Founder and CTO
Josephin is an expert in synthetic chemistry and biocatalysis. She brings specialised knowledge in protein engineering and biocatalysis from her PhD studies and postdoctoral work at the University of Cambridge. Her development of microfluidic screening platforms is crucial for advancing our enzyme technologies.
Dr. Daniel Kaute
Founder and CEO
Daniel has thirty years of experience in high-tech commercialisation, with a strong background in operations and international sales. He has extensive international experience in commercialising high-tech, clean-tech, and medtech innovations. Daniel has worked across Europe and North America, leveraging his global network of business, customer, and academic contacts to bring enabling technologies to market.
Dr. Mariana Rangel Pereira
Founder and CSO
Mariana is an expert in molecular biology and functional metagenomics. She brings extensive experience from her work at São Paulo State University and the University of São Paulo. Mariana’s work in microbial consortia and biocatalyst screening drives our enzyme variant creation and screening activities.
Frank Goebel
Fractional CFO
Frank brings extensive expertise in capital markets, structured finance, and corporate strategy, with a strong background in dynamic industries and international banking. His transactional experience plays a key role in driving Evoralis' growth strategy and corporate development. Frank has also successful
Frank Goebel
Fractional CFO
Frank brings extensive expertise in capital markets, structured finance, and corporate strategy, with a strong background in dynamic industries and international banking. His transactional experience plays a key role in driving Evoralis' growth strategy and corporate development. Frank has also successfully completed the Chartered Financial Analyst® (CFA) program, further strengthening his financial and investment acumen.
Dr. Adam Allen
Biochemist
Adam adds his robust biochemistry background to the team. With a PhD from the John Innes Centre, Adam has significant experience in process optimisations and novel high-throughput assay developments. His role is pivotal in advancing our enzyme development and application strategies.
Dr. Tom Ogden
Biochemist
Tom, a Cambridge PhD in Biological Science, brings extensive expertise in structural biology. Having honed his skills at the Cambridge startup Nuclera, Tom is passionate about enzyme function, design, and characterization. His experience in a dynamic startup environment makes him a valuable asset to our team.